Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,452 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry.
Huisman MV, Teutsch C, Lu S, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Lohmann R, Gurusamy VK, Bartels DB, Lip GYH; GLORIA-AF Investigators. Huisman MV, et al. Among authors: lip gyh. Clin Res Cardiol. 2022 May;111(5):548-559. doi: 10.1007/s00392-021-01957-1. Epub 2022 Mar 16. Clin Res Cardiol. 2022. PMID: 35294623 Free PMC article.
Antithrombotic treatment in atrial fibrillation.
Lip GY, Boos CJ. Lip GY, et al. Heart. 2006 Feb;92(2):155-61. doi: 10.1136/hrt.2005.066944. Epub 2005 Sep 13. Heart. 2006. PMID: 16159980 Free PMC article. Review.
Antithrombotic treatment in atrial fibrillation.
Kalra L, Lip GY; Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. Kalra L, et al. Heart. 2007 Jan;93(1):39-44. doi: 10.1136/hrt.2006.099911. Epub 2006 Sep 4. Heart. 2007. PMID: 16952971 Free PMC article. Review. No abstract available.
Management of atrial fibrillation.
Kakar P, Boos CJ, Lip GY. Kakar P, et al. Vasc Health Risk Manag. 2007;3(1):109-16. Vasc Health Risk Manag. 2007. PMID: 17583181 Free PMC article. Review.
Outcome parameters for trials in atrial fibrillation: executive summary.
Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GY, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G. Kirchhof P, et al. Eur Heart J. 2007 Nov;28(22):2803-17. doi: 10.1093/eurheartj/ehm358. Epub 2007 Sep 25. Eur Heart J. 2007. PMID: 17897924
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.
Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck KH, Lip GY, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G. Kirchhof P, et al. Europace. 2007 Nov;9(11):1006-23. doi: 10.1093/europace/eum191. Epub 2007 Sep 25. Europace. 2007. PMID: 17897925
Atrial fibrillation (chronic).
Boos CJ, Lane DA, Lip GY. Boos CJ, et al. BMJ Clin Evid. 2008 Apr 30;2008:0217. BMJ Clin Evid. 2008. PMID: 19450316 Free PMC article. Review.
Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
Ip J, Waldo AL, Lip GY, Rothwell PM, Martin DT, Bersohn MM, Choucair WK, Akar JG, Wathen MS, Rohani P, Halperin JL; IMPACT Investigators. Ip J, et al. Am Heart J. 2009 Sep;158(3):364-370.e1. doi: 10.1016/j.ahj.2009.07.002. Am Heart J. 2009. PMID: 19699858 Clinical Trial.
3,452 results